Skip to content
10-Q

Quarterly Report

CENTESSA PHARMACEUTICALS PLC CNTA

0001847903-25-000135

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 134.07M sh
Shares Diluted Q2 2025 · Jun 30, 2025 133.68M sh
Shares Diluted Q2 2025 · Jun 30, 2025 133.35M sh
Shares Diluted Q2 2025 · Jun 30, 2024 109.49M sh
Shares Diluted Q2 2025 · Jun 30, 2024 104.69M sh
Capex Q2 2025 · Jun 30, 2025 $126K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$79.7M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$77.87M
Long Term Debt Q2 2025 · Jun 30, 2025 $109.55M
Long Term Debt Q2 2025 · Dec 31, 2024 $108.94M
Short Term Investments Q2 2025 · Jun 30, 2025 $206.48M
Short Term Investments Q2 2025 · Dec 31, 2024 $98.96M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $44.24M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $383.22M
Stockholders Equity Q2 2025 · Jun 30, 2025 $344.92M
Stockholders Equity Q2 2025 · Mar 31, 2025 $386.25M
Stockholders Equity Q2 2025 · Dec 31, 2024 $401.55M
Stockholders Equity Q2 2025 · Jun 30, 2024 $286.97M
Stockholders Equity Q2 2025 · Mar 31, 2024 $215.16M
Stockholders Equity Q2 2025 · Dec 31, 2023 $236.24M
Current Liabilities Q2 2025 · Jun 30, 2025 $29.69M
Current Liabilities Q2 2025 · Dec 31, 2024 $58M
Total Liabilities Q2 2025 · Jun 30, 2025 $147.21M
Total Liabilities Q2 2025 · Dec 31, 2024 $175.25M
Current Assets Q2 2025 · Jun 30, 2025 $300.36M
Current Assets Q2 2025 · Dec 31, 2024 $536.41M
Total Assets Q2 2025 · Jun 30, 2025 $492.13M
Total Assets Q2 2025 · Dec 31, 2024 $576.8M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.38
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.57
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.40
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.78
Eps Basic Q2 2025 · Jun 30, 2025 −$0.38
Eps Basic Q2 2025 · Jun 30, 2025 −$0.57
Eps Basic Q2 2025 · Jun 30, 2024 −$0.40
Eps Basic Q2 2025 · Jun 30, 2024 −$0.78
Sga Expense Q2 2025 · Jun 30, 2025 $11.91M
Sga Expense Q2 2025 · Jun 30, 2025 $24.25M
Sga Expense Q2 2025 · Jun 30, 2024 $11.17M
Sga Expense Q2 2025 · Jun 30, 2024 $24.6M
Net Income Q2 2025 · Jun 30, 2025 −$50.34M
Net Income Q2 2025 · Jun 30, 2025 −$76.48M
Net Income Q2 2025 · Jun 30, 2024 −$43.82M
Net Income Q2 2025 · Jun 30, 2024 −$81.86M
Operating Income Q2 2025 · Jun 30, 2025 −$54.65M
Operating Income Q2 2025 · Jun 30, 2025 −$85.43M
Operating Income Q2 2025 · Jun 30, 2024 −$43.98M
Operating Income Q2 2025 · Jun 30, 2024 −$80.07M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $15M
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $0